欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号ES/H/0623/001
药品名称Olmesartan/Amlodipine/HCT Accord 20 mg /5 mg/12,5 mg film-coated tablets
活性成分
    • amlodipine besilate 6.95 mg
    • hydrochlorothiazide besilate 12.5 mg
    • olmesartan medoxomil 20.0 mg
剂型Film-coated tablet
上市许可持有人Accord Healthcare S.L.U. (Spain)
参考成员国 - 产品名称Spain (ES)
互认成员国 - 产品名称
    • Germany (DE)
      Olmesartan/Amlodipin/ HCT Accord 20 mg/5 mg/12.5 mg Filmtabletten
    • Netherlands (NL)
    • Ireland (IE)
    • Latvia (LV)
      Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Accord 20 mg/5 mg/12,5 mg apvalkotās tabletes
    • Lithuania (LT)
      Olmesartan medoxomil/Amlodipine/Hydrochlorothiazide Accord 20 mg/5 mg/12,5 mg plėvele dengtos tabletės
    • Czechia (CZ)
      Olmesartan/Amlodipin/HCT Accord 20 mg/5 mg/12.5 mg potahované tablety
许可日期2020/03/09
最近更新日期2024/01/19
药物ATC编码
    • C09DX03 olmesartan medoxomil, amlodipine and hydrochlorothiazide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase